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Bifidobacterium Infantis 35624 Protects Against
Salmonella-Induced Reductions in Digestive Enzyme
Activity in Mice by Attenuation of the Host
Inflammatory Response
Erin L. Symonds, PhD1,4, Caitlin O’Mahony, PhD1, Susan Lapthorne, PhD1,2, David O’Mahony, MSc3, John Mac Sharry, PhD3,
Liam O’Mahony, PhD1,3,5 and Fergus Shanahan, MD, FRCPI, FRCP, FACP, FCCP, FACG1,2,3
OBJECTIVES: Salmonella-induced damage to the small intestine may decrease the villi-associated enzyme activity, causing
malabsorption of nutrients and diarrhea, and thus contribute to the symptoms of infection. The objective of this study was to
determine the mechanism by which different doses and durations of Salmonella infection and lipopolysaccharide (LPS) affect
brush border enzyme activity in the mouse, and to determine if the probiotic Bifidobacterium longum subspecies infantis 35624
could attenuate the intestinal damage.
METHODS: BALB/c mice were challenged with Salmonella enterica serovar Typhimurium UK1 at various doses (102–108 colony-
forming unit (CFU)) and durations (106 CFU for 1–6 days). Mice were also treated with B. longum subsp. infantis 35624 for 2 weeks
before and during a 6-day S. Typhimurium challenge (106 CFU), or before injection of LPS. The small intestine was assessed for
morphological changes, mRNA expression of cytokines, and activity of the brush border enzymes sucrase–isomaltase, maltase,
and alkaline phosphatase.
RESULTS: S. Typhimurium infection significantly reduced the activity of all brush border enzymes in a dose- and time-dependent
manner (Po0.05). This also occurred following injection of LPS. Pre-treatment with B. longum subsp. infantis 35624 prevented
weight loss, protected brush border enzyme activity, reduced the small intestinal damage, and inhibited the increase in
interleukin (IL)-10 and IL-8 expression due to Salmonella challenge.
CONCLUSIONS: Salmonella infection reduces the small intestinal brush border enzyme activity in mice, with the level of
reduction and associated weight loss increasing with dose and duration of infection. B. longum subsp. infantis 35624 treatment
attenuated the effect of Salmonella infection on brush border enzyme activity and weight loss, which may be due to modulation of
the host immune response.
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INTRODUCTION
The gastrointestinal tract can be affected by a number of
pathogens that disturb the normal function and cause
diarrhea, with salmonellosis being one of the most common
foodborne diseases. Diarrheal diseases are a leading cause
of childhood morbidity and mortality in developing countries;
however, the use of antibiotic therapy for salmonellosis is
being questioned because of the emergence of multidrug-
resistant strains of Salmonella.1 Alternative therapies and
preventative strategies are therefore required.
The presence of pathogens within the gastrointestinal tract
can cause a number of host immune responses and
pathological effects, including the modification of epithelial
function to enhance penetration across the epithelial barrier
(reviewed in Lu and Walker2). Salmonella is one such
pathogen that attaches to the epithelial cells in the gastro-
intestinal tract, resulting in degeneration of the microvilli and
membrane ruffling (reviewed in Lu and Walker2). This affects
small intestinal function, resulting in decreased brush border
enzyme activity.3–5 Brush border enzymes, such as sucrase–
isomaltase and maltase, play an important role in the
digestion of carbohydrates and therefore reduced activity
results in undigested food in the intestine, causing maldiges-
tive diarrhea,6 which contributes to the gastrointestinal
symptoms of Salmonella infection. The underlying mechan-
isms for decreased enzyme activity have not been completely
determined. Many studies have only assessed enzyme
activity of the ileum as Salmonella is known to appear in the
terminal ileum, cecum, and colon;7 however, since the
jejunum is a main area for nutrient digestion and uptake, it is
important to assess if infection also affects jejunal brush
border enzymes. In addition, studies have mainly assessed
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the effect of infection on the disaccharidase enzymes involved
in carbohydrate digestion, including sucrase–isomaltase and
maltase. Intestinal alkaline phosphatase (ALP) is a brush
border enzyme unrelated to carbohydrate digestion that
catalyses the hydrolysis of phosphomonoesters in an alkaline
environment, and is thought to participate in regulating fat
absorption.8 This enzyme is therefore also important to
assess in disease states, as an alteration to its activity may
affect fat digestion.
There is increasing interest in the use of probiotics for
disease prevention and health benefits. In vitro studies
suggest that certain probiotic strains can inhibit Salmonella
growth,9–11 adhesion12 and cell invasion,13 and alter immune
responses, e.g., by reducing interleukin (IL)-8 secretion14 and
decreasing tumor necrosis factor (TNF)-a production in the
small intestine.15 Few in vivo studies have beenperformed, but
report increased survival, reduced intestinal damage,16,17 and
decreased translocation of Salmonella to the liver and
spleen.18,19 In addition, the probiotic Bifidobacterium infantis
35624 reduces the inflammatory activity associated with
Salmonella infection by the induction of T regulatory cells.20,21
No study has assessed the effect of probiotics on brush border
enzyme activity followingSalmonella infection. It was hypothe-
sized that Salmonella would significantly reduce the digestive
enzyme activity of the gastrointestinal tract, and that treatment
with the probiotic B. longum subspecies infantis 35624 would
attenuate the activation of the inflammatory immune response
and reduce the gastrointestinal damage. The aims of the
following studies were therefore to establish the effect of
different doses and duration of Salmonella infection on small
intestinal function in mice and to determine the effect of B.
longum subsp. infantis 35624 treatment on disease pathology.
Methods
Studies were conducted in specific pathogen-free BALB/c
mice (410 weeks; Harlan UK, Bicester, UK). Mice were
housed in a 12 h light:12 h dark cycle at 21 1C. They were fed a
standard pellet diet and water ad libitum. All studies were
approved by the animal ethics committee of University
College Cork (Cork, Ireland).
Bacterial culture. Challenge doses of Salmonella for the
following studies were prepared by inoculating trypsin soy
broth (Oxoid, Basingstoke, UK) with Salmonella enterica
serovar Typhimurium UK1 and growing it aerobically
overnight (37 1C). The broth was centrifuged (1,600 g,
5min) and the pellet was resuspended in phosphate-buffered
saline (PBS). The colony count was determined by serial
dilution in PBS and spread plating on trypsin soy agar (Oxoid,
Basingstoke, UK). Agar plates were aerobically incubated
(37 1C) for 24 h, following which the bacteria was enumerated
and the appropriate inoculation concentrations could be
prepared by dilution of the culture in PBS.
The probiotic used in the following studies was freeze-dried
B. longum subsp. infantis 35624 (Alimentary Health Ltd, Cork,
Ireland), which was administered to mice via drinking water
that was refreshed daily. The quantity of B. longum subsp.
infantis 35624 added to the drinking water allowed mice to
consume approximately 108 colony-forming units (CFU) per
day. For the study assessing quantification of the bifidobac-
teria within the mouse gastrointestinal tract, a freeze-dried
rifampicin-resistant B. longum subsp. infantis 35624 (sponta-
neous rifampicin-resistant variant) was used.
Effect of Salmonella dose and disease duration on small
intestinal function. To determine the effect of infection
dose on intestinal function, mice were orally inoculated by
placing a pipette tip in the mouth and administering 20 ml of
102, 104 or 106CFU S. Typhimurium UK1 (n¼ 10 per group).
A further two groups (n¼ 8 per group) received 107 or
108CFU. All mice were killed at day 6 post-challenge. The
effect of duration of infection was determined by challenging
mice with 106CFU S. Typhimurium UK1 and being killed at
days 1 (n¼ 10), 3 (n¼ 10) and 6 (n¼ 10) post-challenge.
Results were compared with non-infected mice (n¼ 10).
All S. Typhimurium UK1 challenge concentrations were
confirmed by spread plating on to trypsin soy agar as
described above.
Mice were monitored and weighed throughout the study. At
the study end point, mice were killed via cervical dislocation,
and the small intestine was removed and divided into jejunum
(proximal half) and ileum (distal half). The distal 1 cm sections
of the jejunum and ileum were stored in cassettes in 10%
neutral-buffered formalin (Sigma-Aldrich, St Louis, MO, USA)
for histology. The neighboring 2 cm sections were stored at
80 1C until analyzed for enzyme activity. The remaining
small intestine, spleen, and liver were used for Salmonella
quantification. To investigate the effect of duration of
Salmonella infection on intestinal gene expression of cyto-
kines and chemokines, a subgroup of mice from the duration
of infection study (n¼ 5 per group) had an additional 1 cm
tissue section removed from the jejunum and stored in
RNAlater (Ambion, Warrington, UK) at 80 1C until it was
processed for RNA extraction.
Colonization site of B. longum subsp. infantis 35624 and
effect on small intestinal function. To determine the
colonization site for B. longum subsp. infantis 35624,
healthy mice (n¼ 6) were fed approximately 108CFU per
day rifampicin-resistant B. longum subsp. infantis 35624 in
drinking water for 3 weeks (refreshed daily). After 3 weeks,
mice were euthanized. The liver, spleen, small intestine
(proximal, mid and distal), cecum, and large intestine
(proximal and distal), as well as the removed luminal
contents, were collected. Samples were mechanically
disrupted in PBS in stomacher bags (Seward, Thetford,
UK), and serial dilutions were plated on reinforced clostridial
agar (Merck, Darmstadt, Germany) containing 0.05% L-
cysteine hydrochloride (Sigma-Aldrich) and 50mg/ml
rifampicin (Sigma-Aldrich). Plates were incubated for 48 h
(37 1C) in an anaerobic chamber. The use of rifampicin
eliminated the growth of the other intestinal bacteria on the
plate, and allowed enumeration of the B. longum subsp.
infantis 35624, which was expressed as CFU/g sample.
To determine the effect of B. longum subsp. infantis 35624
on brush border enzyme activity, mice were given 108CFU
B. longum subsp. infantis 35624 or regular water (n¼ 10 per
group). Following 3 weeks of administration, mice were
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euthanized and sections of jejunum were analyzed for
enzyme activity.
Effect of B. longum subsp. infantis 35624 pre-treatment
on Salmonella pathology. Mice (n¼ 6) were administered
108CFU per day B. longum subsp. infantis 35624
(Alimentary Health Ltd) in drinking water for 2 weeks before
and for 6 days following challenge with Salmonella.
S. Typhimurium (106CFU) was orally administered and
mice were euthanized 6 days post-challenge. The jejunum
was removed and stored for histology, RNA extraction and
analysis of enzyme activity. The remaining small intestine,
spleen, and liver were collected for quantification of
S. Typhimurium. Results were compared with age-matched
healthy control mice (n¼ 6) and S. Typhimurium UK1-
infected mice (106CFU, n¼ 6) that received no probiotics.
To investigate the mechanisms underpinning the
Salmonella-induced decrease in digestive enzyme activity,
mice were challenged with lipopolysaccharide (LPS) from
Salmonella. LPS was administered via the intraperitoneal
route (rather than orally) to exclude any mechanism that
may involve morphological alterations to the apical side of
the epithelial cells. Mice were injected (intraperitoneally) with
2mg/kg LPS (Sigma-Aldrich) following 3 weeks of 108CFU
per dayB. longum subsp. infantis 35624 (n¼ 9) or water alone
(n¼ 9). At 3 h following LPS, mice were euthanized. The
jejunum was removed and analyzed for brush border enzyme
activity. The results were compared with age-matched non-
challenged mice (n¼ 9).
Histology. Following storage in 10% neutral-buffered
formalin, intestinal samples were processed and embedded
in paraffin. Cross-sections were cut at 3 mm, attached to
glass slides, and stained with hematoxylin and eosin. Villus
height and crypt depth were determined from more than five
sites. Only well-orientated villi and crypts were assessed and
measurements were made in a blinded manner by two
observers (Olympus BX51 upright microscope with Olympus
DP Soft imaging capturing software).
Enzyme analysis. Intestinal tissue samples were homo-
genized in PBS (T10 basic Ultra-Turrax, IKA, Staufen,
Germany), centrifuged (2,000 g, 10min, 4 1C), and the
supernatant was used in the assays. The samples were
assayed for sucrase–isomaltase and maltase,22 and ALP23
activity using published methods but modified for a 96-well
plate. Enzyme activity was expressed as specific activity
(units per milligram of protein (assessed with the Bradford
protein assay)24). For disaccharidases, 1U was defined as
the activity that produces 1mmol glucose per min per mg
protein. For ALP, 1U was defined as the activity that
hydrolyses 1mmol p-nitrophenol phosphate per min per mg
protein.
Salmonella quantification from mouse tissue. Tissues
were homogenized in PBS in stomacher bags, and DNA was
extracted (DNAeasy tissue kit; Qiagen, Crawley, UK) and
quantified (NanoDrop Technologies, Wilmington, DE). Levels
of Salmonella were quantified with real-time polymerase
chain reaction using the LightCycler TaqMan Master kit
(Roche Diagnostics, East Sussex, UK). DNA (20 ng) was
used in the reaction with universal probe library and primers
for the invasion gene specific to S. Typhimurium UK1
(designed using Roche Probelibrary system; Roche;
Table 1). Cycling conditions were 95 1C for 10min, and 45
cycles of 95 1C for 10 s, followed by 55 1C for 30 s and 72 1C
for 30 s. Absolute quantification of Salmonella was performed
by relating the polymerase chain reaction signal to a
standard curve of S. Typhimurium UK1 DNA.
Gene expression. Tissue sections were homogenized in
lysis buffer (Stratagene, Milton Keynes UK) using MagNA
Lyser Green Beads (Roche), and RNA was extracted
(Absolutely RNA Miniprep kit; Stratagene) and quantified
(Nanodrop). RNA quality was assessed with the RNA 2100
Pico Labchip Kit (Agilent Technologies, Amstelveen, The
Netherlands). To prepare cDNA, RNA (1 mg) was annealed to
random primers (150 ng) (Roche) and then reverse
transcribed at 42 1C for 50min in a reaction containing
25mM MgCl2, 10mM deoxynucleoside triphosphate mix, 5
reaction buffer, RNase inhibitor, and reverse transcriptase
enzyme (Promega, Southampton, UK). The reaction was
terminated by heat inactivation (70 1C, 15min).
Quantitative real-time reverse transcriptase-polymerase
chain reaction was performed using the LightCycler TaqMan
Master kit (Roche). cDNA (5 ml) was used in the reaction with
1 ml of each primer and 0.2ml universal probe library. Cycling
conditions were as described for Salmonella quantification.
Table 1 Primer sequences for mouse mRNA targets with probe library number (Roche Diagnostics)
Primer Forward sequence (50–30) Reverse sequence (50–30) ProbeLibrary#
S. Typhimurium UK1 invasion gene TGTCCTCCGCTCTGTCTACTT ATCAACAATGCGGGGATCT 9
Sucrase-isomaltase CACAATGCTGAAGGCTATGC TGCCTTGATGTGTTTACCAAAA 32
Maltase-glucoamylase ATTCAAGTTCGCCGAAAGAG TGAAGGTGAAGCCGAGGA 95
Alkaline phosphatase TCAGACATCAGCTAAGAACCTCA TCCAACTGCCCCTTTAGGAT 83
IFN-g ATCCTGGAGGAACTGGCAAAA TTCAAGACTTCAAAGAGTCTGAGGT 21
TNF-a CTGTAGCCCACGTCGTAGC TTGAGATCCATGCCGTTG 25
TGF-b GAGCTGCTTATCCCAGATTCA GGCAGTGGAGACGTCAGATT 20
IL-1b TGTAATGAAAGACGGCACACC TCTTCTTTGGGTATTGCTTGG 78
KC ATAATGGGCTTTTACATTCTTTAACC AGTCCTTTGAACGTCTCTGTCC 2
IL-10 CAGAGCCACATGCTCCTAGA GTCCAGCTGGTCCTTTGTTT 41
IFN-g, interferon-g; IL, interleukin; KC, keratinocyte chemoattractant: murine homolog for human IL-8; TGF-b, transforming growth factor-b; TNF-a, tumor necrosis
factor-a.
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Primers for mouse sucrase–isomaltase, maltase, ALP, inter-
leukin (IL)-1b, IL-10, tumor necrosis factor (TNF)-a, trans-
forming growth factor (TGF)-b, keratinocyte chemoattractant
(KC: murine homolog for human IL-8), and interferon (IFN)-g
were designed using Roche ProbeLibrary system (Table 1).
Amplification of b-actin was included as an endogenous
control. The parameter threshold was defined as the fractional
cycle number at which the fluorescence generated by
cleavage of the probe passed a fixed threshold above the
baseline value. Relative mRNA expression levels were
calculated with the formula 2DDCT, where the threshold cycle
(CT) of the target gene is normalized to b-actin expression and
relative to the control group.
Data analysis. Data are expressed as mean±s.e. Compa-
rison between control and challenged mice was performed
with a one-way analysis of variance, with a P-value o0.05
considered significant. Where significant, the Holm–Sidak
post-hoc test was performed to determine the differences
compared with the control mice. Correlations were performed
with a Spearman rank test. All statistical analyses were
performed with SigmaStat (version 3.0.1a; SPSS Inc.,
Chicago, IL).
RESULTS
Salmonella dose on small intestinal function. Following
6 days of Salmonella infection all mice had diarrhea and
weight loss, with the weight loss greater in the mice
challenged with 106, 107, and 108CFU compared with
healthy controls (weight change compared with baseline:
non-infected mice¼ 1.41±0.87%, 102CFU¼1.95±2.50%,
104CFU¼2.84±1.19%, 106CFU¼7.04±2.62%, 107CFU¼
11.37±2.66%, 108CFU¼10.50±1.38%, Po0.001).
Two mice that had been challenged with 108CFU had to
be euthanized early because of severity of disease and
therefore were excluded from the analysis. Quantification of
Salmonella showed no differences in the levels recovered
from the liver, spleen, or small intestine from the different
challenge groups (Table 2). No Salmonella was recovered
from the non-challenged mice. There was a negative
correlation between infection dose with jejunal villi length
(r¼0.764, Po0.001) and crypt depth (r¼0.518,
Po0.001), with villi and crypt length reduced to 70% of
control levels. These structural alterations were restricted to
the jejunum as changes to the ileum did not reach
significance (P40.05).
Infection with Salmonella significantly reduced enzyme
activity. Sucrase–isomaltase, maltase, and ALP activity
was reduced in the jejunum (Po0.001; Figure 1a) when mice
were challenged with 104CFU and higher doses of Salmo-
nella, and there were significant reductions in sucrase–
isomaltase and maltase in the ileum for challenge doses
of 106CFU and above (Po0.01; Figure 1b). This occurred
in a dose-dependent manner for both the jejunum and
ileum (jejunum: sucrase–isomaltase r¼0.679, maltase
r¼0.629, ALP r¼0.553, Po0.001; ileum: sucrase–iso-
maltase r¼0.496, maltase r¼0.480, Po0.001), and was
correlated with villi length in the jejunum (sucrase–isomaltase
r¼ 0.377, maltase r¼ 0.368, ALP r¼ 0.318, Po0.05). There
was also a negative correlation between jejunal enzyme
activity and weight loss (sucrase–isomaltase r¼0.412,
maltase r¼0.359, ALP r¼0.385, Po0.05).
Table 2 Levels ofS. TyphimuriumUK1 (log10CFU/g tissue) in the liver, spleen, and small intestine of mice following challenge with 10
2, 104, 106, 107, and 108CFUS.
Typhimurium UK1
S. Typhimurium UK1 inoculation dose
102CFU (n¼10) 104CFU (n¼ 10) 106CFU (n¼10) 107CFU (n¼ 8) 108CFU (n¼6)
Liver 4.33±0.95 5.19±0.88 6.08±0.44 6.37±0.47 6.69±0.28
Spleen 6.55±0.31 6.87±0.20 6.69±0.43 6.43±0.96 7.39±0.26
Small intestine 6.26±0.24 6.28±0.24 5.27±0.78 4.77±0.68 4.58±0.32
CFU, colony-forming unit.
Data are mean±s.e. There were no significant differences between Salmonella recovered between the different challenge doses (P40.05).
Figure 1 Brush border enzyme activity of (a) the jejunum and (b) the ileum
following 6 days of challenge with different doses of S. Typhimurium UK1: non-
infected (white, n¼ 10), 102 (light gray, n¼ 10), 104 (dark gray, n¼ 10), 106
(diagonal stripe, n¼ 10), 107 (thatched, n¼ 8) and 108 (horizontal stripe, n¼ 6)
colony-forming unit (CFU). The results are expressed as % of non-infected value.
Data are mean±s.e., with *representing Po0.05 compared with non-infected
mice. ALP, alkaline phosphatase; CFU, colony-forming unit.
Attenuation of Salmonella pathology by bifidobacteria
Symonds et al.
4
Clinical and Translational Gastroenterology
Infection duration on small intestinal function. Duration
of Salmonella infection was associated with weight loss
(r¼0.521, Po0.001) and became significant at day 6
compared with non-infected mice (weight change compared
with baseline: non-infected mice¼ 1.41±0.87%, day 1¼
2.16±0.97%, day 3¼1.32±0.71%, day 6¼6.64±
2.34%, Po0.005). Following 24 h of infection, Salmonella
was detected in the liver, spleen, and small intestine, and
these levels did not significantly change over the 6 days of
infection (Table 3; P40.05). There were significant changes
in the enzyme activity, with sucrase–isomaltase, maltase,
and ALP activity in the jejunum significantly reduced at all
days of infection (Po0.0001; Figure 2a), whereas in the
ileum the changes were more variable, with a decrease in
maltase activity at all days post-infection, but a decrease in
sucrase–isomaltase activity after only 3 days (Figure 2b).
There was a negative correlation between the activity of all
enzymes and duration of infection in the jejunum (sucrase–
isomaltase r¼0.679, maltase r¼0.632, ALP r¼0.510,
Po0.005), and for sucrase–isomaltase and maltase in the
ileum (sucrase–isomaltase r¼0.748, maltase r¼0.470,
Po0.005).
Infection with Salmonella increased IL-10, KC, interferon-g,
and transforming growth factor-b mRNA expression, with
most peaking by day 1 post-infection and remaining elevated
(Po0.05; Figure 3). There were slight increases in TNF-a and
IL-1b expression; however, these did not reach statistical
significance (P40.05; Figure 3).
Colonization site of B. longum subsp. infantis 35624 and
the effect on small intestinal function. Viable B. longum
subsp. infantis 35624 was not detected either in the small
intestinal tissue or contents, or in the spleen or in the liver. It
was detected in the cecal tissue and contents (at similar
levels), but was at 102- to 103-fold higher levels in the
proximal and distal colon luminal contents compared with
their corresponding tissue sections (Figure 4). Consumption
of B. longum subsp. infantis 35624 (for 3 weeks) did not
significantly alter the brush border enzyme activity (P40.05)
Table 3 Levels of S. Typhimurium UK1 (log10CFU/g tissue) in the liver, spleen,
and small intestine of mice following challenge with 106 S. typhimurium UK1 at
days 1, 3, and 6
Days post-infection
Day 1 Day 3 Day 6
Liver 4.25±0.95 4.13±0.95 3.76±0.89
Spleen 6.41±0.29 6.24±0.33 5.40±0.71
Small intestine 5.43±0.67 5.96±0.36 4.54±0.66
CFU, colony-forming unit.
Data are mean±s.e. N¼10 per group. There were no significant differences
betweenSalmonella recoveredbetween thedifferent challengedurations (P40.05).
Figure 2 Brush border enzyme activity of (a) the jejunum and (b) the ileum over
6 days of infection with 106 S. Typhimurium UK1 (n¼ 10 per group). The results are
expressed as % of non-infected value, with diamonds representing sucrase–
isomaltase activity, squares representing maltase activity and the broken line
representing alkaline phosphatase activity. Data are mean±s.e., with ‘‘a’’ indicative
of Po0.05 compared with the sucrase–isomaltase non-infected values, ‘‘b’’
indicative of Po0.05 compared with the maltase non-infected values and ‘‘c’’
indicative of Po0.05 compared with the alkaline phosphatase non-infected values.
CFU, colony-forming unit.
Figure 3 mRNA expression of cytokines and chemokines in the jejunum of non-
infected mice (white column), and S. Typhimurium UK1-infected mice at day 1 (light
gray), day 3 (striped) and day 6 (dark gray). Data are mean±s.e., with values
expressed relative to non-infected values. *Po0.05 compared with control values.
N¼ 5 per group.
Figure 4 Levels of viable B. longum subsp. infantis 35624 in the cecum,
proximal and distal colon (gray), and in the corresponding luminal contents (striped).
Data are mean±s.e., with *indicating Po0.05. N¼ 6 per group. CFU, colony-
forming unit.
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or the villi or crypt length of the jejunum (P40.05, data not
shown).
Effect of B. longum subsp. infantis 35624 pre-treatment
on Salmonella pathology. The jejunum is an area of high
nutrient uptake, and as greater physiological alterations were
occurring here following infection, we only assessed this site
for the subsequent probiotic treatment studies. Salmonella
infection caused weight loss, which was evident from day 3
post-infection (Po0.05; Figure 5). Pre-treatment with B.
longum subsp. infantis 35624 prevented the Salmonella-
associated weight loss, with no differences between weight
of this group and non-infected mice. B. longum subsp.
infantis 35624 also attenuated the reduction in enzyme
activity, with sucrase–isomaltase activity significantly greater
than the non-treated Salmonella-infected mice (Po0.005;
Figure 6). B. longum subsp. infantis 35624 reduced the
Salmonella-induced decrease in the villi length (villi length
as the percentage of control: Salmonella¼ 71.3±5.3%;
B. longum subsp. infantis 35624¼ 87.7±6.6%), but did not
alter the levels of Salmonella in the spleen, liver, or small
intestine (Table 4; P40.05).
Salmonella infection increased mRNA expression of cyto-
kines and chemokines of the jejunal tissue (Figure 7).
B. longum subsp. infantis 35624 reduced the increase in
IL-10 and KC expression (Po0.05). Salmonella infection
also decreased mRNA expression of sucrase–isomaltase
and ALP, while B. longum subsp. infantis 35624 prevented
some of the decrease in sucrase–isomaltase expression
(P40.05 compared with healthy levels).
At 3 h following LPS injection, mice exhibited diarrhea
associated with a decrease in enzyme activity (Po0.005;
Figure 8), which was an average of 37% of healthy levels.
Treatment with B. longum subsp. infantis 35624 for 3 weeks
before the LPS challenge reduced this degree of change so
that brush border enzyme levels were between 56 and 66% of
healthy levels and not significantly different to unchallenged
mice (P40.05; Figure 8).
Figure 5 Weight change in non-infected mice (diamonds), S. Typhimurium
UK1-infected mice with B. longum subsp. infantis 35624 pre-treatment (squares),
and S. Typhimurium UK1-infected mice (broken line). The values are mean
percentage weight change compared with the baseline weight±s.e. *Po0.05
compared with non-infected mice. N¼ 6 per group.
Figure 6 Brush border enzyme activity in non-infected mice (white),
S. Typhimurium UK1-infected mice (light gray) and in B. longum subsp. infantis
35624-pre-treated S. Typhimurium UK1-infected mice (dark gray). The results are
expressed as % of non-infected value. Data are mean±s.e., with * representing
Po0.05 between indicated groups. N¼ 6 per group. ALP, alkaline phosphatase.
Table 4 Levels of S. Typhimurium UK1 (log10CFU/g tissue) in the liver, spleen,
and small intestine of mice challenged with 106 S. Typhimurium UK1 that had
been pre-treated with water or 108CFU/day B. longum subsp. infantis 35624
Treatment
Water B. infantis 35624
Liver 6.88±0.38 6.46±0.20
Spleen 7.83±0.54 6.73±0.41
Small intestine 5.80±0.69 5.74±0.42
CFU, colony-forming unit.
Data are mean±s.e. N¼6 per group. There were no significant differences
between Salmonella recovered between the different treatments (P40.05).
Figure 7 mRNA expression of (a) cytokines and chemokines and (b) brush
border digestive enzymes in the jejunum for non-infected mice (white column),
S. Typhimurium UK1-infected mice (light gray), and B. longum subsp. infantis
35624-pre-treated S. Typhimurium UK1-infected mice (dark gray). Data are
mean±s.e., with values expressed relative to non-infected values. *Po0.05
compared with non-infected values. N¼ 6 per group. ALP, alkaline phosphatase;
IFN, interferon; IL, interleukin; KC, keratinocyte chemoattractant; TGF, tumor
growth factor; TNF, tumor necrosis factor.
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DISCUSSION
Salmonella is a leading cause of bacterial gastroenteritis that
disturbs the normal function of the gut and results in diarrhea;
however, the molecular mechanisms by which Salmonella
interacts with the host to cause disease are not well under-
stood. This study has shown that S. Typhimurium UK1
decreases brush border enzyme activity in a dose- and time-
dependent manner. These changes are most likely due to a
combination of small intestinal morphological alterations and
the host immune inflammatory response possibly altering
gene expression and protein activity of the enzymes. These
physiological alterations and the associated weight loss also
occurred with LPS administration, but were attenuated by pre-
treatment with the probiotic B. longum subsp. infantis 35624.
The small intestinal brush border enzymes are often
affected in diseases involving enteropathy of the gastro-
intestinal tract. Following entry ofSalmonella into the host, the
pathogen attaches to the intestinal surface25 and causes local
degeneration of the intestinal microvilli26 and stunting of the
villi.7 Salmonella can then pass through the epithelium and
spread to the lymph nodes, liver, spleen, and blood.27 This
study has shown that Salmonella causes significant damage
to the small intestine of mice. As also seen with humans,
infection caused weight loss and diarrhea. Examination of the
small intestine showed functional changes to the entire length,
with villi blunting and reductions to all brush border enzymes.
The jejunum showed more damage, which is significant for
health as this is a main area for nutrient digestion. It has been
previously shown that Salmonella infection reduces brush
border enzyme activity,3–5 but this wasmainly assessed in the
ileum, with measurements limited to lactase. In our study, we
found that all enzyme activity was reduced, showing that
changes are not limited only to the disaccharidases. However,
it is not clear whether this is due to morphological damage or
changes in mRNA expression. It has been previously
assumed that changes to brush border enzymes are due to
villi damage from Salmonella entry, yet a study has shown
that these physiological changes can occur in the absence
of obvious histology changes.28 A previous study showed
S. Typhimurium enterotoxin administration in a rabbit ileal
loop model reduced sucrase and lactase activity, but did not
affect mRNA expression.5 In this study, Salmonella infection
caused a reduction in sucrase–isomaltase and ALP expres-
sion but not maltase.
Enzyme activity as well as body weight of the Salmonella-
infected mice decreased in a dose- and duration-dependent
manner. In the jejunum, the activity of all enzymes assessed
had decreased by day 1, whereas in the ileum the functional
changeswere smaller, with sucrase–isomaltase levels reduced
at day 3 post-infection and maltase affected by day 6. In
humans, the incubation period of Salmonella is typically 6–48h
and is followed by abdominal pain and diarrhea. Following oral
administration in animals, Salmonella has a rapid transit
through the intestine. Oral S. Typhimurium challenge of mice
causes high numbers of bacteria in the cecum within the first
few hours, with less in the small intestine.27 Another study
reported that the jejunumand ileumare positive forS. enteritidis
by 8h post-inoculation, which peaks by 24–36h.29 Following
intestinal colonization the infection becomes systemic, with
bacteria appearing in the spleen by day 3, with numbers rapidly
increasing over the next 4 days.27 By using quantitative
polymerase chain reaction, we were able to detect Salmonella
in the spleen and in the liver by 24h post-challenge. These
levels and those in the small intestine did not change
significantly over the 6 days.
This study challenged mice with different doses of Salmo-
nella and investigated the outcome on bacterial colonization
and translocation, weight loss, and small intestinal function. It is
generally believed that a large inoculum (105–1010 bacteria) is
required to initiate infection, to overcome the stomach acidity
and to compete with the normal gut microbiota.30 However, we
found decreases in enzyme activity with lower doses (104
bacteria), and that by day 6 post-infection, levels recovered
from the spleen and small intestine were the same, regardless
of the initial dose. This is in agreement with a study that found
that initial penetration at 6 h was dependent on dose, but by day
3 there was no significant difference in S. Typhimurium
recovered from the spleen.27
Salmonella infection causes structural and functional
changes to epithelial cells, thought to be mediated by bacterial
toxins. Epithelial cells sense the microbial environment and
prime the host immune response by releasing cytokines in
response to bacterial signals. Immune functionsmay play a role
as inflammatory cells and cytokines can infiltrate the intestinal
tract during enteric bacterial infections. Studies show increases
in pro-inflammatory cytokines and chemokines in response
to Salmonella infection, including increased TNF-a31 and
IL-8.32,33 In this study, we found that Salmonella-infected mice
had an upregulation of the pro-inflammatory cytokines and
chemokines interferon-g and KC (IL-8), as well as an increase
in IL-10 and transforming growth factor-b expression in the
jejunum. This is in agreement with previous studies.34–36 Other
studies have also reported an increase in TNF-a following
Salmonella infection, 31 but we did not observe this in the
mouse jejunum. The reason for this discrepancy is likely to be
that the upregulation of TNF-a is an early transient induction.
TNF-a plays an important role in host defense against
infectious agents, but also mediates some of the pathology,
with increases occurring within 6h post-infection.31 We did not
measure cytokine expression until 24h post-challenge, and
therefore may have missed this early immune response.
Figure 8 Jejunal brush border enzyme activity in non-infected mice (white), in
lipopolysaccharide (LPS)-challenged mice (light gray) and in B. longum subsp.
infantis 35624-pre-treated LPS-challenged mice (dark gray). The results are
expressed as % of non-infected value. Data are mean±s.e., with *representing
Po0.05 compared with non-infected values. N¼ 9 per group. ALP, alkaline
phosphatase.
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The role of T lymphocytes and cytokines in the Salmonella-
related pathology of brush border microvilli rather than villi is
largely unknown;28 however, the upregulation of pro-inflam-
matory cytokine expressionmay be an underlyingmechanism
for the observed decrease in enzyme activity. Some
cytokines, including IL-6 and interferon-g, have been found
to downregulate the gene expression of sucrase–isomal-
tase.37 This study also reported that TNF-a induced a small
increase in sucrase–isomaltase expression, while IL-1b had
no effect on the enzyme. Expression of the disaccharidase
lactase was not affected by any of the cytokines.37 This
suggests that the effect of each cytokine on enzyme
expression is specific and selective, and this may explain
why changes to the gene expression of maltase in this study
were not observed with infection.
To further investigate the mechanisms underlying the
reduction in brush border enzyme activity, mice were injected
with Salmonella LPS. This caused a similar decrease in
enzyme activity to that found with oral administration of
Salmonella. LPS is a major surface component of the
outer membrane and is an important virulence factor of
S. Typhimurium.38 Bacterial LPS is the principal component in
the pathogenesis of endotoxic shock, and evokes an acute
phase response, resulting in excessive production of pro-
inflammatory cytokines.39 Studies have also reported LPS to
decrease digestive enzyme activity in vitro and in vivo.40,41
Our results support the concept that decreases in enzyme
activity are not due to Salmonella damage of cells alone (as
the LPS was not administered on the apical side of the
intestine), but rather related to the host immune response.
The pro-inflammatory signaling events from Salmonella are
also thought to be triggered on the basolateral surface of the
epithelial cells through toll-like receptors.42,43
There are several studies that investigated probiotic
treatment on Salmonella infection; however, no study
determined whether probiotics can attenuate the damage
caused to the small intestinal enzymes. Probiotics improve
clinical outcomes in Salmonella infection by increasing
survival, decreasing weight loss, reducing intestinal
damage,16,17 and decreasing Salmonella translocation,18,19
but this is the first study to demonstrate that probiotics reduce
the alterations caused to the brush border enzymes.
B. longum subsp. infantis 35624 also prevented weight loss
and decreased the pathology associated with Salmonella
infection. The mechanisms for the beneficial effects of
probiotics are largely unknown; however, it could include
reducing intestinal infections by decreasing adhesion and
invasion,12,13 competing for nutrients within the intestinal
lumen,44 or by modulating host immune response.14,15,45 In
this study, B. longum subsp. infantis 35624 reduced the small
intestinal damage associated with Salmonella infection. It is
unlikely that these changes are from decreased adhesion,
because B. longum subsp. infantis 35624 did not change the
levels ofSalmonella recovered from the small intestine. This is
in agreement with some studies, which found that despite
probiotics causing a decrease in disease severity, they do not
alter the intestinal or fecal levels of Salmonella.16,46 The
effects of the probiotic treatment were also not due to
decreased Salmonella translocation and dissemination,
because there were no significant changes to the Salmonella
levels in the liver and spleen; however, it is possible that
changes to Salmonella levels could have been found in the
mesenteric nodes, but this was not assessed. The beneficial
effects of the probiotic were also unlikely to be due to
B. longum subsp. infantis 35624 interacting withSalmonella or
competing for nutrients within the small intestine because the
probiotic was not detected in the small intestine, only within
the cecum and large intestine (mainly luminal contents), nor
was the probiotic enhancing the levels of brush border
enzyme activity. The lack of B. longum subsp. infantis
35624 in the small intestine was unexpected as high levels
were found in the cecum, but this could be explained either by
the probiotic having a fast transit time through the small
intestine or perhaps levels in the small intestine were below
the sensitivity of our measuring technique and therefore its
presence, even in low quantities could be having a biological
effect. However, more likely we propose that the attenuation
of the small intestinal damage is from an altered host immune
response. This is supported by the finding that B. longum
subsp. infantis 35624 reduced the intestinal damage caused
not only bySalmonella, but also by LPS, a chemical agent that
was not present on the luminal side of the gastrointestinal
tract. Previous work also shows that bifidobacteria can
stimulate the immune system and decrease intestinal
inflammation47 via induction of T regulatory cells.20,21
Probiotics are considered a potentially important strategy to
modulate inflammatory responses in the gastrointestinal tract
as they can enhance the host immune response and positively
affect indigenous microbiota. In this study, B. longum subsp.
infantis 35624 suppressed the expression of KC (IL-8) and
reduced IL-10. IL-8 secretion correlates with the invasion of
epithelial cells by Salmonella48 and is a mediator of mucosal
inflammation,49 whereas IL-10 is an immunosuppressive
compound that is triggered by Salmonella infection and
depresses resistance to infection by blocking an effective
immune response.35 Decreased IL-8 with B. longum subsp.
infantis 35624 treatment agrees with previous findings;14
however, decreased IL-10 may be due to a direct effect of
the probiotic on the Salmonella, such as decreasing its ability
to trigger immunosuppressive activity. The reduced IL-8 and
IL-10 expression observed with probiotic treatment may
contribute to the attenuation of damage to the brush border
enzymes as well as the decrease in weight loss, as there is an
association between weight loss and enzyme activity,
suggesting that malnutrition is contributing to the weight loss
in mice.
Salmonella is one of the most extensively characterized
bacterial pathogens and is a leading cause of bacterial
gastroenteritis. Despite this, not much is understood at a
molecular level as to how Salmonella interacts with the host to
cause disease. This study has shown how gastrointestinal
and immune functions are altered with different levels and
durations of infection, with systemic infection and functional
changes to the small intestinal enzymes occurring as early
as 24 h post-infection. In addition, this is the first study to
show the beneficial effects of a probiotic on enzyme activity
following Salmonella challenge. The exact mechanisms are
still to be determined, but it is likely due to modulation of the
host immune system. Bifidobacteria are an attractive choice
as probiotics as they make up one of the predominant
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populations of the normal human colonic microbiota;16
however, improved knowledge of the molecular mechanisms
will allow for the selection of the best probiotic species, strains
or substrates to protect against specific pathogens.
Acknowledgements. We would like to acknowledge Jay Radford and
Frances O’Brien for their involvement in the care of the mice, and Graham
Sherlock for his technical assistance. This work was funded in part by a CSET
science foundation Ireland grant. The funding bodies had no involvement
in this study.
CONFLICT OF INTEREST
Guarantor of the article: Erin L. Symonds, PhD.
Specific author contributions: Involved with the design of
the trial, collected and analyzed samples throughout all
studies, analyzed the data, and drafted and revised the
paper: Erin L. Symonds; involved with the design and conduct
of the trial, assisted with data analysis, and revised the draft
paper: Caitlin O’Mahony; involved with the design and
conduct of the trial and revised the draft paper: Susan
Lapthorne; involved with the design and conduct of the trial
and revised the draft paper: David O’Mahony; involved with
the design and conduct of the trial and revised the draft paper:
JohnMac Sharry; involved with the design of the trial, assisted
with data interpretation, and revised the draft paper: Liam
O’Mahony; assisted with data interpretation revised the draft
paper: Fergus Shanahan.
Financial support: This work was supported (salary) by a CJ
Martin post-doctoral fellowship (E.L.S.) awarded by the
National Health and Medical Research Council of Australia
(ID 357702).
Potential competing interests: None.
Study Highlights
WHAT IS CURRENT KNOWLEDGE
|Salmonella is one of the most common foodborne
diseases that cause diarrhea.
|Salmonella pathology includes intestinal damage and
functional changes, as well as alterations to the
host immune response.
|There is a need for preventative therapy.
WHAT IS NEW HERE
|Salmonella infection in mice reduces the activity of the
small intestinal brush border enzymes, sucrase–isomal-
tase, maltase, and ALP, in a dose- and time-dependent
manner.
| Intraperitoneal administration of LPS from Salmonella
also decreases small intestinal brush border enzyme
activity.
|Pre-treatment with the probiotic B. longum subspecies
infantis 35624 prevents the weight loss and attenuates
the changes to brush border enzyme activity and pro-
inflammatory cytokine expression induced by Salmonel-
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